FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024708384> ?p ?o ?g. }

• W2024708384 endingPage "332" @default.
• W2024708384 startingPage "325" @default.
• W2024708384 abstract "Both thalidomide and dexamethasone have been shown to inhibit the production of tumour necrosis factor alpha (TNF-alpha), but little is known of their cellular selectivity. Inhibition of monocyte TNF-alpha expression has been implicated in the clinical efficacy of thalidomide, and it has been suggested that the drug modulates only monocyte-derived cytokines. Given the importance of T lymphocyte responses in immunological disorders in which treatment with thalidomide has been successful, it is pertinent to study the effects of this drug on T cell-derived TNF-alpha. In the present investigations we have examined the influence of both thalidomide and dexamethasone on mitogen-induced elaboration of TNF-alpha by CD3+ peripheral blood mononuclear cells (PBMC) and the T cell line MOLT-4. PBMC from healthy human volunteers were stimulated optimally with phytohaemagglutinin (PHA) in the presence of varying concentrations of thalidomide or dexamethasone, and supernatants assayed for TNF-alpha and interleukin 2 (IL-2). Concurrently, PHA-stimulated PBMC were treated with 1 x 10(-1) mM thalidomide or dexamethasone and the cells fixed, permeabilised, stained with anti-CD3 and anti-TNF-alpha fluorescently labelled antibodies and analysed by flow cytometry. MOLT-4 cells were cultured in the presence or absence of the drugs following activation with phorbol myristate acetate (PMA)/ionophore, and supernatants analysed by enzyme-linked immunosorbent assay (ELISA) for cytokine expression. Thalidomide was found to inhibit PBMC-derived TNF-alpha, but not IL-2. In contrast, dexamethasone down-regulated both TNF-alpha and IL-2 in a dose-dependent manner. Thalidomide and dexamethasone both suppressed intracellular levels of TNF-alpha in CD3+ PBMC, reducing percentages of double positive staining cells by 28 and 52%, respectively, compared with controls. In addition, TNF-alpha production by CD3- PBMC was inhibited by 31% by thalidomide and by 47% by dexamethasone. In order to determine whether thalidomide was acting directly on T cells, or indirectly through effects on accessory cells, TNF-alpha production in the T cell line MOLT-4 was investigated. TNF-alpha secretion by PMA/ionophore activated MOLT-4 cells was reduced by 80% following thalidomide treatment and close to background levels following dexamethasone treatment. To verify that thalidomide was acting selectively to down-regulate TNF-alpha, IL-2 production by MOLT-4 cells was also measured and found to be unaffected by the drug. In contrast, dexamethasone reduced MOLT-4-derived IL-2 levels by 20%. These observations suggest that thalidomide, in addition to its known inhibitory effect on monocyte-derived TNF-alpha, is capable also of down-regulating T cell-derived TNF-alpha in a direct and selective manner. In addition, the inhibition of intracellular levels of TNF-alpha strengthens the evidence that the inhibitory effect of thalidomide is at the level of transcription and/or translation and does not reduce cellular TNF-alpha secretion. Such effects could explain the efficacy of thalidomide treatment in various immunological disorders where T cell activation plays an important role in the pathogenesis of the disease." @default.
• W2024708384 created "2016-06-24" @default.
• W2024708384 creator A5013019467 @default.
• W2024708384 creator A5039090860 @default.
• W2024708384 creator A5042582706 @default.
• W2024708384 creator A5043044428 @default.
• W2024708384 creator A5085384594 @default.
• W2024708384 creator A5091157379 @default.
• W2024708384 date "1999-06-01" @default.
• W2024708384 modified "2023-10-07" @default.
• W2024708384 title "Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor α by thalidomide: comparisons with dexamethasone" @default.
• W2024708384 cites W1493836238 @default.
• W2024708384 cites W1522773084 @default.
• W2024708384 cites W1717444875 @default.
• W2024708384 cites W1938023575 @default.
• W2024708384 cites W1971417559 @default.
• W2024708384 cites W1972752943 @default.
• W2024708384 cites W1978869885 @default.
• W2024708384 cites W1990083672 @default.
• W2024708384 cites W1998761125 @default.
• W2024708384 cites W2000969879 @default.
• W2024708384 cites W2014085694 @default.
• W2024708384 cites W2020052352 @default.
• W2024708384 cites W2033667523 @default.
• W2024708384 cites W2040257465 @default.
• W2024708384 cites W2043601349 @default.
• W2024708384 cites W2044454543 @default.
• W2024708384 cites W2093951597 @default.
• W2024708384 cites W2122596233 @default.
• W2024708384 cites W2123073660 @default.
• W2024708384 cites W2125559109 @default.
• W2024708384 cites W2144382102 @default.
• W2024708384 cites W2159746652 @default.
• W2024708384 cites W2176899369 @default.
• W2024708384 cites W2177327503 @default.
• W2024708384 cites W2339981418 @default.
• W2024708384 doi "https://doi.org/10.1016/s0165-2478(99)00055-3" @default.
• W2024708384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10424439" @default.
• W2024708384 hasPublicationYear "1999" @default.
• W2024708384 type Work @default.
• W2024708384 sameAs 2024708384 @default.
• W2024708384 citedByCount "27" @default.
• W2024708384 countsByYear W20247083842015 @default.
• W2024708384 countsByYear W20247083842016 @default.
• W2024708384 countsByYear W20247083842017 @default.
• W2024708384 countsByYear W20247083842019 @default.
• W2024708384 countsByYear W20247083842020 @default.
• W2024708384 countsByYear W20247083842022 @default.
• W2024708384 countsByYear W20247083842023 @default.
• W2024708384 crossrefType "journal-article" @default.
• W2024708384 hasAuthorship W2024708384A5013019467 @default.
• W2024708384 hasAuthorship W2024708384A5039090860 @default.
• W2024708384 hasAuthorship W2024708384A5042582706 @default.
• W2024708384 hasAuthorship W2024708384A5043044428 @default.
• W2024708384 hasAuthorship W2024708384A5085384594 @default.
• W2024708384 hasAuthorship W2024708384A5091157379 @default.
• W2024708384 hasConcept C126322002 @default.
• W2024708384 hasConcept C134018914 @default.
• W2024708384 hasConcept C137061746 @default.
• W2024708384 hasConcept C17991360 @default.
• W2024708384 hasConcept C202751555 @default.
• W2024708384 hasConcept C203014093 @default.
• W2024708384 hasConcept C2776364478 @default.
• W2024708384 hasConcept C2778690821 @default.
• W2024708384 hasConcept C2779609412 @default.
• W2024708384 hasConcept C2780401358 @default.
• W2024708384 hasConcept C2781184567 @default.
• W2024708384 hasConcept C55493867 @default.
• W2024708384 hasConcept C71924100 @default.
• W2024708384 hasConcept C86803240 @default.
• W2024708384 hasConcept C98274493 @default.
• W2024708384 hasConceptScore W2024708384C126322002 @default.
• W2024708384 hasConceptScore W2024708384C134018914 @default.
• W2024708384 hasConceptScore W2024708384C137061746 @default.
• W2024708384 hasConceptScore W2024708384C17991360 @default.
• W2024708384 hasConceptScore W2024708384C202751555 @default.
• W2024708384 hasConceptScore W2024708384C203014093 @default.
• W2024708384 hasConceptScore W2024708384C2776364478 @default.
• W2024708384 hasConceptScore W2024708384C2778690821 @default.
• W2024708384 hasConceptScore W2024708384C2779609412 @default.
• W2024708384 hasConceptScore W2024708384C2780401358 @default.
• W2024708384 hasConceptScore W2024708384C2781184567 @default.
• W2024708384 hasConceptScore W2024708384C55493867 @default.
• W2024708384 hasConceptScore W2024708384C71924100 @default.
• W2024708384 hasConceptScore W2024708384C86803240 @default.
• W2024708384 hasConceptScore W2024708384C98274493 @default.
• W2024708384 hasIssue "2-3" @default.
• W2024708384 hasLocation W20247083841 @default.
• W2024708384 hasLocation W20247083842 @default.
• W2024708384 hasOpenAccess W2024708384 @default.
• W2024708384 hasPrimaryLocation W20247083841 @default.
• W2024708384 hasRelatedWork W133691617 @default.
• W2024708384 hasRelatedWork W1976485394 @default.
• W2024708384 hasRelatedWork W1977124608 @default.
• W2024708384 hasRelatedWork W2011717172 @default.
• W2024708384 hasRelatedWork W2067693794 @default.
• W2024708384 hasRelatedWork W2077416684 @default.
• W2024708384 hasRelatedWork W2077925316 @default.

• next